+ All Categories
Home > Documents > 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8...

2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8...

Date post: 16-Jul-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
6
Atrial Fibrillation How to make ORDER out of CHAOS Julia Shih, VMD, DACVIM (Cardiology) August 18, 2019 Depolarization & ECG Depolarization & ECG Depolarization & ECG Loss of atrial contraction Normally ~10-15% of total cardiac output At rapid heart rates, accounts for up to 30% ventricular filling Tachycardia reduces diastolic filling time Further drop in stroke volume and cardiac output Tachycardia increases myocardial work and oxygen demand Chronic tachycardia results in myocardial failure Structural and electrical remodeling Hemodynamic Consequences Lone atrial fibrillation Absence of overt cardiac disease Giant breed dogs Acquired atrial fibrillation Secondary to cardiac disease resulting in secondary atrial enlargement Dogs: DCM, CVD Cats: HCM, RCM, UCM Lone vs. Acquired
Transcript
Page 1: 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8 mg/kg/hr for 6 hours •Then 0.4 mg/kg/hr for 18 hours –Chronic Oral Dosing •10-25mg/kg

Atrial FibrillationHow to make ORDER out of CHAOS

Julia Shih, VMD, DACVIM (Cardiology)

August 18, 2019

Depolarization & ECG

Depolarization & ECG Depolarization & ECG

• Loss of atrial contraction– Normally ~10-15% of total cardiac output

– At rapid heart rates, accounts for up to 30% ventricular filling

• Tachycardia reduces diastolic filling time– Further drop in stroke volume and cardiac output

• Tachycardia increases myocardial work and oxygendemand

• Chronic tachycardia results in myocardial failure

• Structural and electrical remodeling

Hemodynamic Consequences

• Lone atrial fibrillation– Absence of overt cardiac disease

– Giant breed dogs

• Acquired atrial fibrillation– Secondary to cardiac disease resulting in

secondary atrial enlargement

– Dogs: DCM, CVD

– Cats: HCM, RCM, UCM

Lone vs. Acquired

Page 2: 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8 mg/kg/hr for 6 hours •Then 0.4 mg/kg/hr for 18 hours –Chronic Oral Dosing •10-25mg/kg

• Lone AF– Incidental finding– Mild exercise

intolerance

• Acquired AF– Weakness– Lethargy– Syncope– Cough– Tachypnea– Dyspnea

Diagnosis: History, Clinical Signs

• Auscultation– Irregularly irregular rhythm

– Variable intensity S1, S2, S3

– Absent S4

– +/- Heart murmur

– +/- Tachycardia

– +/- Tachypnea, Dyspnea,

Crackles, Dull lung sounds (pleural effusion)

• Variable pulse quality

• +/- Jugular venous distension, abdominal fluid wave, palemucous membranes

Diagnosis: Physical Exam

• ECG Findings– Irregularly irregular rhythm

• Irregular R-R intervals

– Absent P waves

– Presence of fibrillation waves (F waves)• Fine baseline undulation

• May not be apparent

– Narrow/supraventricular QRS morphology

– Tachycardia

Diagnosis: ECG Diagnosis: ECG

Diagnosis: ECG

Atrial Fibrillation

50mm/s

25mm/s

Differential Diagnoses (ECG)

Atrial Flutter

Page 3: 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8 mg/kg/hr for 6 hours •Then 0.4 mg/kg/hr for 18 hours –Chronic Oral Dosing •10-25mg/kg

Differential Diagnoses (ECG)

Atrial Fibrillation with LBBB 

Ventricular Tachycardia 

Differential Diagnoses (ECG)

Multiform ventricular tachycardia 

OR

Atrial fibrillation with a right bundle branch block and VPCs

Differential Diagnoses (ECG)

Atrial fibrillation with a right bundle branch block

Differential Diagnoses (ECG)

Focal atrial tachycardia with right bundle branch block

Other Diagnostics

• Blood Work

• Thoracic Radiographs

• Echocardiography

Methods of Treatment

• Rhythm Control - Cardioversion– Restoration of sinus rhythm

– Electrical or pharmacological cardioversion

– Patients may revert back to atrial fibrillation

• Rate Control– Slow the heart rate

– Improves diastolic filling (cardiac output)

Page 4: 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8 mg/kg/hr for 6 hours •Then 0.4 mg/kg/hr for 18 hours –Chronic Oral Dosing •10-25mg/kg

Electrical Cardioversion

• Options– Transthoracic

• Monophasic vs. Biphasic Shock

– Intracardiac (TVEC)

– Transesophageal

Electrical Cardioversion

Synchronization Shock Sinus Rhythm

Electrical Cardioversion

Synchronization Mode Off

Shock Ventricular Fibrillation

Electrical Cardioversion - Risks

• Overall Safe – Complications Rare

• Theoretical Risks:– Anesthetic complications

– Shock induced myocardial damage

– Thromboembolic complications

– Induction of ventricular arrhythmias

– Induction of bradycardia

– Sudden death

Electrical Cardioversion

• Success Rate > 90%

• Maintenance of Sinus Rhythm– Lone AF: 690 days

– Acquired AF: 73 days

Pharmacological Cardioversion

• Greatest success with recent onset atrial fibrillation• Atrial fibrillation begets atrial fibrillation• Limited success• Requires continuous cardiac monitoring for:

– Sinus node dysfunction– Atrioventricular block– Ventricular arrhythmias– Atrial flutter

• Drug options:– Quinidine– Amiodarone

Page 5: 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8 mg/kg/hr for 6 hours •Then 0.4 mg/kg/hr for 18 hours –Chronic Oral Dosing •10-25mg/kg

Pharmacological Cardioversion

• Other Options– Lidocaine

• 2mg/kg IV

– Procainamide• 6 – 8 mg/kg IV slow

(up to 20mg/kg IV)

• 20-50 mcg/kg/min CRI

– Humans:• Propafenone (Class Ic)

• Flecainide (Class Ic)

• Dofetilide (Class III)

• Ibutilide (Class III)

Rate Control

• Prolong AV Refractory Period & Slow Conduction

• ABCDs for SVT

‐ Amiodarone/Sotalol‐ Beta-blockers

‐ Calcium Channel Blockers‐ Digoxin

Rate Control – Beta Blockers

• β-Blockers– IV

• Esmolol 0.25 – 0.5 mg/kg IV slow followed by a 50 – 200 mcg/kg/min CRI

– PO• Atenolol D: 0.25 – 1.5 mg/kg PO q12-24h

C: 6.25 – 12.5 mg/cat PO q12-24h

• Metoprolol D: 0.4 – 1.0 mg/kg PO q8-12h

C: 2 – 15 mg/cat PO q8h

• Propanolol D: 0.2 - 1.0 mg/kg PO q8h

C: 2.5 – 5.0 mg/cat PO q8-12h

Rate Control – CCBs

• Calcium Channel Blockers– Not affected by sympathetic drive

– Diltiazem:• IV: 0.1 - 0.25 mg/kg IV slow followed by a

2 - 6 mcg/kg/min CRI

• PO: 0.5 – 4 mg/kg PO q8h

– Give slowly IV

– Side Effects• Gastrointestinal

• Lethargy

Rate Control – Digoxin

• Digoxin

– Parasympathetic activation, sympathetic inhibition

– Na+‐K+ ATPase Inhibitor

– Negative chronotrope, positive inotrope

– Overridden by heightened sympathetic tone

– Slow onset, long t1/2– Dose: 

• D: 0.003 – 0.005 mg/kg PO q12h

• C: 0.03125 mg/cat PO q48h

Rate Control – Digoxin

• Digoxin Toxicity– Gastrointestinal (anorexia, vomiting, diarrhea)

– Proarrhythmia• AV Block

• Bigeminy

• Atrial and ventricular tachyarrhythmias

• Treat arrhythmias with Class I agents (e.g. lidocaine)

– Potentiated by hypokalemia and renal dysfunction

– Digoxin Levels• Check trough levels 6 - 8 hours post pill

• Goal Therapeutic Range: 0.6 - 1.2 ng/mL

Page 6: 2. CVCA PVMA Conference Atrial Fibrillation · •2.5 mg/kg IV slow over 5-10 min •Follow by 0.8 mg/kg/hr for 6 hours •Then 0.4 mg/kg/hr for 18 hours –Chronic Oral Dosing •10-25mg/kg

Rate Control – Sotalol

• Sotalol– Potassium Channel Blocker

– Beta-Blocker

– Dose:• 1-3 mg/kg PO q12h

– Side Effects:• Gastrointestinal

• Negative inotropy

• Bronchoconstriction

Rate Control – Amiodarone

• Amiodarone– Potassium Channel Blocker (Class III Antiarrhythmic)

– Also has class I, II, IV activity

– IV Dose (Nexterone) – Numerous protocols• 2.5 mg/kg IV slow over 5-10 min

• Follow by 0.8 mg/kg/hr for 6 hours

• Then 0.4 mg/kg/hr for 18 hours

– Chronic Oral Dosing• 10-25mg/kg q12-24 PO

• Goal: Reduce to 5mg/kg PO q24h over 2-3 weeks

Rate Control - Amiodarone

• Amiodarone– Side Effects

• Gastrointestinal

• Neutropenia

• Thrombocytopenia

• Hepatotoxicity

• Hypothyroidism

• Keratopathy

• Drug Interactions– (antiarrhythmics, theophylline, methotrexate, cyclosporine)

• Hypersensitivity

Goal Heart Rate

• Goal Heart Rate– In hospital ECG: < 160 bpm

– Breed and patient dependent

• Large and giant breed dogs normally have a sinus rate< 90 beats/min and require a lower goal heart rate

– Maintain cardiac output

• Monitor via Holter– Ideally <125 bpm

Thank You!


Recommended